Navigation Links
Renal Advantage and Liberty Dialysis Deal Completed
Date:12/22/2010

FRANKLIN, Tenn. and MERCER ISLAND, Wash., Dec. 22, 2010 /PRNewswire/ -- Renal Advantage and Liberty Dialysis, which last month agreed to combine to form the third largest provider of dialysis services in the U.S., today announced that they have closed their deal.  The transaction – terms of which were not disclosed – was completed on December 17, 2010.  The combined organization has 5,300 employees serving more than 19,000 patients in 260 locations in 32 states.

"The completion of our deal signals a new era in the dialysis industry, uniting two patient-focused, physician driven and employee-oriented companies with great autonomy to build their brands," said Mark Caputo, founder of Liberty Dialysis and CEO of the combined organization.  "This transaction allows us to take advantage of the combined financial strength, purchasing power, and systems investment of two leaders in the industry."  

"As we begin a new year with change on the health care horizon, we are well positioned for robust growth in the future through this deal," said Michael D. Klein, who has served as chief executive officer of RAI. "By focusing on the patient, partnering with talented nephrologists, and recruiting the best caregivers, we will optimize patient outcomes through active participation of both patients and caregivers."

Liberty Dialysis has been among the fastest growing dialysis companies for each of the last eight years, achieving 25 percent annual growth rates.  Similarly, RAI has nearly doubled in size since its inception over five years ago.  To accommodate its rapid growth, RAI has moved into a new 54,000 square foot office building in the McEwen Building in Franklin, Tenn., a suburb of Nashville.  RAI will consolidate its existing corporate offices into this one location, improving efficiency while providing for its growth needs for the future. Liberty's existing administrative offices in conjunction with RAI's are forming a shared services organization supporting the two sister companies.  

About Liberty DialysisWith more than 112 dialysis clinics, Liberty Dialysis, is dedicated to providing outstanding care for patients with kidney disease, and a rewarding career experience for its caregivers.  Liberty has a history of developing clinics in underserved communities in conjunction with local physicians and non-profit organizations.  Liberty partners with local nephrologists and hospitals in developing, owning and operating these centers.  Liberty was founded in 2002 by Mark Caputo and Bob Santelli in conjunction with Bain Capital.  Liberty's historic rapid growth has been funded, in part, by subsequent equity investments from Bain Capital, KRG Capital Partners, and Ignition Partners, each of whom will continue as equity sponsors of the merged organization.  For more information on the company, please visit the website for Liberty Dialysis at www.libertydialysis.com

Barclays Capital and Bank of America Merrill Lynch served as financial advisors to Liberty Dialysis Holdings, Inc in relation to its transaction with RAI.

About Renal AdvantageBased in Brentwood, Tenn., Renal Advantage provides dialysis services to patients with chronic kidney failure, also known as end-stage renal disease (ESRD). Renal Advantage and Liberty Dialysis recently announced their merger which clearly positions the combined organization as the third largest provider of dialysis services in the U.S.  The shared services organization will maintain their unique brands in the markets they serve, and have 5,300 employees serving more than 19,000 patients in 260 locations in 32 states.  RAI also advances pioneering laboratory services through RenaLab, a state-of-the-art independent clinical laboratory located in Jackson, Miss.  Founded by veteran healthcare executives, RAI's growth plan began with its acquisition of 73 dialysis centers in October 2005.   For more information, visit RAI's website at www.renaladvantage.com.

Raymond James & Associates and Moelis & Company served as financial advisors to Renal Advantage in relation to this merger.Contact:

Todd Smith (M) 615.202.7944 (O) 615.873.5663todd.smith@deanesmithmedia.com
'/>"/>

SOURCE Renal Advantage
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pfizer Announces Positive Phase 3 Trial Results for Axitinib in Patients With Previously-Treated Metastatic Renal Cell Carcinoma (mRCC)
2. The Renal Anemia Market Shows Signs of Stabilization but Changes are Occurring in the Bone and Mineral Metabolism Market
3. Reportlinker Adds Renal Cell Carcimona Cancer Drug Futures
4. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
5. Amgen to Review Results From TREAT and Propose Updates to ESA Labeling for Chronic Renal Failure Patients at an FDA Advisory Committee Meeting Today
6. New Report by BioTrends Examines the Treatment of Renal Anemia in China
7. Results From Argos Therapeutics Arcelis™ Immunotherapy Phase 2 Study for Treatment of Renal Cell Carcinoma (RCC) Accepted for Poster Presentation at Ninth International Kidney Cancer Symposium
8. Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
9. Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical Trial of AGS-16M8F for Renal Cancer
10. Hospira Begins Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
11. Genomic Health Announces Results From the Largest Genomic Analysis of Localized Clear Cell Renal Carcinoma at American Society of Clinical Oncology (ASCO) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
Breaking Medicine Technology:
(Date:6/27/2016)... Lafayette, California (PRWEB) , ... ... ... a pioneer in the patient payment industry today announced its strategic partnership ... and health system workflows. , The two companies’ proven, proprietary technology combine ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever ... Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation ... as home to some of the world’s leading providers of cereal and other breakfast ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women ... diagnosed with endometriosis. These women need a treatment plan to not only alleviate ... that can help for preservation of fertility and ultimately achieving a pregnancy. The ...
(Date:6/25/2016)... ... 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can ... CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn ... X . Simply select a ProHand generator and drag it above media or text ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
Breaking Medicine News(10 mins):